SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 157 filers reported holding SERES THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $130,967 | -43.6% | 55,028 | +13.6% | 0.00% | – |
Q2 2023 | $232,080 | -33.1% | 48,451 | -20.8% | 0.00% | – |
Q1 2023 | $347,078 | +30.5% | 61,213 | +28.9% | 0.00% | – |
Q4 2022 | $265,911 | +31.6% | 47,484 | +50.9% | 0.00% | – |
Q3 2022 | $202,000 | +47.4% | 31,477 | -21.3% | 0.00% | – |
Q2 2022 | $137,000 | -65.7% | 40,014 | -28.7% | 0.00% | – |
Q1 2022 | $399,000 | -82.9% | 56,159 | -79.9% | 0.00% | -100.0% |
Q4 2021 | $2,333,000 | +326.5% | 279,979 | +256.5% | 0.00% | – |
Q3 2021 | $547,000 | -51.2% | 78,542 | +67.2% | 0.00% | -100.0% |
Q2 2021 | $1,121,000 | -13.5% | 46,966 | -25.3% | 0.00% | 0.0% |
Q1 2021 | $1,296,000 | +16.0% | 62,914 | +38.0% | 0.00% | 0.0% |
Q4 2020 | $1,117,000 | +36.2% | 45,592 | +57.5% | 0.00% | 0.0% |
Q3 2020 | $820,000 | +638.7% | 28,953 | +23.9% | 0.00% | – |
Q2 2020 | $111,000 | +146.7% | 23,368 | +88.4% | 0.00% | – |
Q1 2020 | $45,000 | +2.3% | 12,401 | -5.6% | 0.00% | – |
Q4 2019 | $44,000 | +10.0% | 13,143 | +28.6% | 0.00% | – |
Q3 2019 | $40,000 | -13.0% | 10,222 | -31.8% | 0.00% | – |
Q2 2019 | $46,000 | -71.1% | 14,996 | -35.9% | 0.00% | – |
Q1 2019 | $159,000 | +55.9% | 23,387 | +2.7% | 0.00% | – |
Q4 2018 | $102,000 | -85.5% | 22,766 | -75.5% | 0.00% | – |
Q3 2018 | $705,000 | -8.6% | 93,095 | +3.8% | 0.00% | – |
Q2 2018 | $771,000 | -40.1% | 89,714 | -48.9% | 0.00% | -100.0% |
Q1 2018 | $1,287,000 | -44.1% | 175,667 | -22.7% | 0.00% | 0.0% |
Q4 2017 | $2,302,000 | +55.6% | 227,190 | +146.1% | 0.00% | 0.0% |
Q3 2017 | $1,479,000 | -28.0% | 92,316 | -49.3% | 0.00% | 0.0% |
Q2 2017 | $2,054,000 | -28.3% | 181,962 | -28.4% | 0.00% | -50.0% |
Q1 2017 | $2,864,000 | -17.2% | 254,290 | -27.3% | 0.00% | -33.3% |
Q4 2016 | $3,460,000 | -18.5% | 349,643 | +1.2% | 0.00% | 0.0% |
Q3 2016 | $4,246,000 | +1116.6% | 345,569 | +2761.4% | 0.00% | – |
Q2 2016 | $349,000 | +52.4% | 12,077 | +39.4% | 0.00% | – |
Q1 2016 | $229,000 | +205.3% | 8,666 | +305.3% | 0.00% | – |
Q4 2015 | $75,000 | +7.1% | 2,138 | -10.8% | 0.00% | – |
Q3 2015 | $70,000 | -91.3% | 2,398 | -87.7% | 0.00% | -100.0% |
Q2 2015 | $808,000 | – | 19,474 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
Knott David M Jr | 470,000 | $2,251 | 0.90% |
GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |